Nursing and Health Professions
Telemonitoring
100%
Blood Pressure
56%
Obstructive Lung Disease
40%
Breast Cancer
40%
Mild Cognitive Impairment
40%
Cognitive Defect
40%
Diagnostic Accuracy
40%
Clinician
37%
Intensive Care
25%
Symptom
24%
Metastatic Breast Cancer
24%
Cost Effectiveness Analysis
23%
Practice Guideline
20%
Continuous Glucose Monitoring
20%
Lung Cancer
20%
Cancer Therapy
20%
Cost Utility Analysis
20%
Time to Treatment
20%
Coughing
20%
Socioeconomic Status
20%
Respiratory Distress
20%
Dyspnea
20%
Hemoglobin A1c
20%
Insulin Dependent Diabetes Mellitus
20%
Transient Ischemic Attack
20%
Blood Clotting Factor Concentrate
20%
Hemoglobins
20%
Ulcer
20%
Systemic Sclerosis
20%
Scleroderma
20%
Guiding Catheter
20%
Coronary Angiography
20%
Hospital Discharge
20%
Patient Experience
20%
PsycINFO
19%
Self Monitoring
18%
Comorbidity
15%
Case Management
15%
Primary Medical Care
13%
Cancer Diagnosis
13%
Embase
13%
Ischemic Heart Disease
13%
Disease
13%
Disease Exacerbation
11%
Confidence Interval
10%
Socialized Medicine
10%
Hospital Setting
10%
Immunotherapy
10%
CINAHL
10%
Artificial Respiration
10%
Medicine and Dentistry
Insulin Dependent Diabetes Mellitus
40%
Breast Cancer
40%
Clinician
30%
Randomized Controlled Trial
28%
Hemoglobin A1c
27%
Self Monitoring
27%
Blood Glucose
27%
Intensive Care
25%
Coughing
24%
Metastatic Breast Cancer
24%
Dyspnea
23%
Remote Patient Monitoring
20%
Symptom
20%
Blood Pressure
20%
Cystic Fibrosis
20%
Lung Cancer
20%
Respiratory Distress
20%
Flushing
20%
Fatigue (Symptom)
20%
Transient Ischemic Attack
20%
Apoplexy
20%
Socioeconomic Status
20%
Subgroup Analysis
20%
Hemoglobins
20%
Time to Treatment
20%
Absence
20%
Computed Tomography of the Heart
20%
Reproducibility
20%
Early Psychosis
20%
Early Intervention in Psychosis
20%
Scleroderma
20%
Venous Ulcer
20%
Systemic Scleroderma
20%
Mixed Methods
20%
Morquio Syndrome
20%
TRPM8
20%
Tiprelestat
20%
Determinants of Health
20%
Patient Experience
20%
Artificial Respiration
20%
Angina pectoris
20%
Coronary Angiography
20%
Randomized Clinical Trials
20%
Comorbidity
20%
Ivacaftor
18%
APACHE II
15%
Arm
15%
Case Management
15%
Cancer Diagnosis
13%
Adverse Event
10%
Pharmacology, Toxicology and Pharmaceutical Science
Coughing
24%
Talimogene Laherparepvec
20%
Respiratory Distress
20%
Dyspnea
20%
Lung Cancer
20%
Breast Cancer
20%
Cystic Fibrosis
20%
Metastatic Breast Cancer
20%
Metastatic Melanoma
20%
Symptom
20%
Blood Clotting Factor Concentrate
20%
Systemic Sclerosis
20%
Scleroderma
20%
Ulcer
20%
Morquio Syndrome
20%
Tiprelestat
20%
Replacement Therapy
20%
Glycogen Storage Disease Type 2
20%
Ivacaftor
18%
Immunotherapy
12%
Population Study
10%
Comorbidity
10%
Regulator Protein
9%
Disease
8%
Finger Ulcer
8%
Ipilimumab
6%
Adverse Event
6%
Granulocyte Macrophage Colony Stimulating Factor
5%
Melanoma
5%
